Normal pregnancy and healthy child after continued exposure to gliclazide and ramipril during pregnancy

Annals of Pharmacotherapy

Volumn 43, Issue 1, 2009, Pages 147-149

  Kolagasi, Oykun ^a   Sari, Funda ^b   Akar, Munire ^a   Sari, Ramazan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Gliclazide; Pregnancy; Ramipril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLICLAZIDE; GLUCOSE; INSULIN; ISOPHANE INSULIN; METHYLDOPA; ORAL ANTIDIABETIC AGENT; RAMIPRIL; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; DRUG SAFETY; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FETOTOXICITY; FETUS MALFORMATION; GESTATION PERIOD; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPOGLYCEMIA; INFANT; INSULIN TREATMENT; MACROSOMIA; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; BLOOD; DIABETES MELLITUS, TYPE 2; LIVE BIRTH; NEWBORN; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY IN DIABETICS;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GLICLAZIDE; HUMANS; HYPERTENSION; INFANT, NEWBORN; LIVE BIRTH; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RAMIPRIL;

EID: 58549100899     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L332     Document Type: Article

References (19)

1. Ghanem FA, Movahed A. Use of antihypertensive drugs during pregnancy and lactation. Cardiovasc Ther 2008;26:38-49.
2. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008;51:960-9.
3. Guideline Development Group. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 2008;336:714-7.
4. Gestational diabetes mellitus. Position statements. Diabetes Care 2003;26(suppl):S103-5.
5. Coustan DR. Pharmacological management of gestational diabetes: an overview. Diabetes Care 2007;30(suppl 2):S206-8.
6. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257-65.
7. Shotan A, Widerhorn J, Hurst A, et al. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994;96:451-6.
8. Reece EA, Homko CJ. Diabetes mellitus in pregnancy: what are the best treatment options? Drug Saf 1998;18:209-20.
9. Steel JM, Johnstone FD, Hepburn DA, et al. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ 1990;301:1070-4.
10. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 1991;265:731-6.
11. Elliott BD, Schenker S, Langer O, et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994;171:653-60.
12. Moore TR. Glyburide for the treatment of gestational diabetes. A critical appraisal. Diabetes Care 2007;30(suppl 2):S209-13.
13. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
14. Rochon M, Rand L, Roth L, et al. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol 2006;195:1090-4.
15. Yaris F, Yaris E, Kadioglu M, et al. Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. Reprod Toxicol 2004;18:619-21.
16. Ferris TF, Weir EK. Effects of Captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit. J Clin Invest 1983;71:809-15.
17. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51.
18. Hanssens M, Keirse MJ, Vankelecom F, et al. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128-35.
19. Tabacova S, Little R, Tsong Y, et al. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003;12:633-46.